Literature DB >> 30027649

Role of direct oral anticoagulants in the treatment of cancer-associated venous thromboembolism: guidance from the SSC of the ISTH.

A A Khorana1, S Noble2, A Y Y Lee3, G Soff4, G Meyer5, C O'Connell6, M Carrier7.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30027649     DOI： 10.1111/jth.14219

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  74 in total

1.  Direct oral anticoagulants in gastrointestinal malignancies: is the convenience worth the risk?

Authors:  Namisha Thapa; Joseph Shatzel; Thomas G Deloughery; Sven R Olson
Journal:  J Gastrointest Oncol       Date:  2019-08

Review 2.  Anticoagulation Strategies in Patients With Cancer: JACC Review Topic of the Week.

Authors:  Ramya C Mosarla; Muthiah Vaduganathan; Arman Qamar; Javid Moslehi; Gregory Piazza; Robert P Giugliano
Journal:  J Am Coll Cardiol       Date:  2019-03-26       Impact factor: 24.094

Review 3.  Anticoagulation in Cancer Patients: a Summary of Pitfalls to Avoid.

Authors:  Harsh K Patel; Alok A Khorana
Journal:  Curr Oncol Rep       Date:  2019-02-04       Impact factor: 5.075

Review 4.  Managing the competing risks of thrombosis, bleeding, and anticoagulation in patients with malignancy.

Authors:  Hanny Al-Samkari; Jean M Connors
Journal:  Blood Adv       Date:  2019-11-26

Review 5.  Platelet cut-off for anticoagulant therapy in thrombocytopenic patients with blood cancer and venous thromboembolism: an expert consensus.

Authors:  Mariasanta Napolitano; Giorgia Saccullo; Marco Marietta; Monica Carpenedo; Giancarlo Castaman; Elisabetta Cerchiara; Antonio Chistolini; Laura Contino; Valerio De Stefano; Anna Falanga; Augusto B Federici; Elena Rossi; Rita Santoro; Sergio Siragusa; Valerio De Stefano; Anna Falanga; Alberto Tosetto; Giuseppe Avvisati; Monica Carpenedo; Augusto B Federici; Marco Marietta; Mariasanta Napolitano; Elena Rossi; Cristina Santoro; Giancarlo Castaman; Elisabetta Cerchiara; Antonio Chistolini; Laura Contino; Maria Gabriella Mazzucconi; Ilaria Nichele; Laura Russo; Roberto Santi; Rita Carlotta Santoro; Sergio Siragusa; Giuseppe Tagariello
Journal:  Blood Transfus       Date:  2018-10-24       Impact factor: 3.443

Review 6.  Prevention and Treatment of Cancer-Associated Venous Thromboembolism: a Review.

Authors:  Kristen M Sanfilippo; Tzu-Fei Wang
Journal:  Curr Treat Options Cardiovasc Med       Date:  2019-11-20

Review 7.  Evaluation of direct oral anticoagulants for the treatment of cancer-associated thrombosis: an update.

Authors:  A Franco-Moreno; L Cabezón-Gutiérrez; M Palka-Kotlowsa; M Villamayor-Delgado; M García-Navarro
Journal:  J Thromb Thrombolysis       Date:  2019-04       Impact factor: 2.300

8.  Temporal Trends in the Practice Pattern for Venous Thromboembolism in Japan: Insight From JROAD-DPC.

Authors:  Yugo Yamashita; Takeshi Morimoto; Yusuke Yoshikawa; Hidenori Yaku; Yoko Sumita; Michikazu Nakai; Koh Ono; Takeshi Kimura
Journal:  J Am Heart Assoc       Date:  2020-01-10       Impact factor: 5.501

9.  Is there a role for low-dose DOACs as prophylaxis?

Authors:  Alexander T Cohen; Beverley J Hunt
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

10.  Non-vitamin K Antagonist Oral Anticoagulants (NOAC) as an Alternative Treatment Option in Tumor-Related Venous Thromboembolism.

Authors:  Jan Beyer-Westendorf; Robert Klamroth; Stephan Kreher; Florian Langer; Axel Matzdorff; Hanno Riess
Journal:  Dtsch Arztebl Int       Date:  2019-01-18       Impact factor: 5.594
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.